Helperby Therapeutics Addresses A Clear Unmet Need In Areas Of Significant Market Value

Helperby has three development candidates in clinical trials:

  • HY-001 (Urinary Tract Infection) - Phase I completed
  • HY-004 (Nasal MRSA) - Phase II
  • HY-007 (Consumer Antibacterial) - Market ready

View full development candidate pipeline ยป

We are actively seeking business development partners.

We help other companies to rescue their antibiotics from resistance

Helperby has worked with companies which are in different stages of development.

Please contact us to discuss your requirements.